Novavax to Participate in 2024 Jefferies Global Healthcare Conference
Novavax (Nasdaq: NVAX) announced its participation in the 2024 Jefferies Global Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Novavax (Nasdaq: NVAX) announced its participation in the 2024 Jefferies Global Healthcare Conference.
The event includes a Fireside Chat on June 6, 2024, from 12:30 – 12:55 p.m. ET in New York, NY, moderated by Roger Song, MD, CFA, an Equity Research Analyst in Biotechnology. John C. Jacobs, Novavax's President and CEO, will represent the company.
Additionally, Novavax will hold investor meetings on the same day. A replay of the fireside session will be available on the company's website for 30 days post-conference.
Positive
- Novavax's participation in a high-profile conference increases visibility and investor engagement.
- Representation by CEO John C. Jacobs indicates strong leadership presence.
- Availability of session replay enhances accessibility for interested shareholders.
Negative
- No immediate financial data or clinical results were announced, providing actionable insights for investors.
- Potential investor concerns if no new information is divulged during the conference.
Details
News Market Reaction – NVAX
The recorded move for NVAX in the trading session of this news was +0.93%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Details: | ||||||
Fireside Chat | ||||||
Date: | Thursday, June 6, 2024 | |||||
Time: | 12:30 – 12:55 p.m. Eastern Time (ET) | |||||
Location: | ||||||
Moderator: | Roger Song, MD, CFA, Equity Research Analyst – Biotechnology | |||||
Novavax participant: | John C. Jacobs, President and Chief Executive Officer | |||||
Conference | ||||||
Event: | Investor Meetings | |||||
Date: | Thursday, June 6, 2024 | |||||
Recordings
A replay of the recorded fireside session will be available through the Events & Presentations page of the Company's website at ir.novavax.com for 30 days from the date of the conference.
About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in
Contacts:
Investors
Erika Schultz
240-268-2022
ir@novavax.com
Media
Giovanna Chandler
240-720-7804
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-2024-jefferies-global-healthcare-conference-302158433.html
SOURCE Novavax, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.